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Abstract The fate of myelin-forming oligodendrocytes
in the spinal cord of Lewis rats with acute and chronic re-
lapsing experimental autoimmune encephalomyelitis (EAE)
was studied using the pre-embedding immunolabelling
technique with the Rip monoclonal antibody which
specifically labels the cytoplasm of the cell body and
processes of the mature oligodendrocyte. Morphologi-
cally normal Rip-positive (Rip+) cells were found in close
contact with demyelinated axons at the onset of demyeli-
nation and during the course of disease, indicating that
oligodendrocytes survive the acute demyelinating insult.
Occasional Rip+ oligodendrocytes were undergoing mito-
sis at the time of onset of neurological signs. These mi-
totic oligodendrocytes were present in both the grey and
white matter. The majority of the mitotic oligodendro-
cytes had processes in direct contact with myelin sheaths
for considerable lengths, indicating that they were myeli-
nating cells. This study indicates that oligodendrocytes
survive the acute demyelinating insult in EAE and that
mature myelinating oligodendrocytes are able to undergo
mitosis.
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Introduction
The fate of oligodendrocytes, the myelin-forming cells in
the central nervous system (CNS), in inflammatory de-
myelinating disorders such as multiple sclerosis and ex-
perimental autoimmune encephalomyelitis (EAE) is an
interesting and controversial issue. Previous studies have
reached different conclusions on whether the myelin
sheath or the oligodendrocyte is the primary target of the
immune response. It is also unclear whether mature
myelinating oligodendrocytes are able to proliferate, al-
though it is well established that astrocytes and microglia
are able to divide in response to CNS injury.
Although oligodendrocytes have been reported to be
present in established demyelinated lesions in EAE [4,
19], it is not known whether these cells represent oligo-
dendrocytes that have survived the acute demyelinating
insult or whether they are immigrants from surrounding
tissue or newly generated cells. The observed increase in
oligodendrocyte numbers in EAE [21, 29] indicates pro-
liferation of cells of the oligodendrocyte lineage. Prolifer-
ation of oligodendrocyte progenitors may contribute to
this but it is also possible that there is proliferation of ma-
ture myelin-forming oligodendrocytes. It has been re-
ported that mature oligodendrocytes can proliferate in de-
myelinating diseases [1, 8, 28] and after CNS trauma [16,
17]. However, this has been based on the nuclear incorpo-
ration of tritiated thymidine which is not specific for mi-
tosis, as it can also occur during DNA repair [35]. Mature
oligodendrocytes displaying mitotic figures have not been
demonstrated. Furthermore, the definitive identification
of oligodendrocytes by standard light and electron mi-
croscopy is often difficult because of the morphological
similarities between oligodendrocytes and macrophages/
microglia [13].
In the present study, we have studied the fate of oligo-
dendrocytes in EAE using the technique of pre-embed-
ding immunolabelling with the Rip monoclonal antibody,
which specifically labels the cytoplasm of the cell bodies
and processes of myelinating and pro-myelinating oligo-
dendrocytes [3, 5, 7, 10] but does not label oligoden-
droglial progenitors [30]. Our results indicate that oligo-
dendrocytes survive the acute demyelinating insult in
EAE and that mature myelinating oligodendrocytes are
able to undergo mitosis.
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Male Lewis rats (JC strain), 7–9 weeks old, were obtained from the
Central Animal Breeding House of The University of Queensland
and from the Animal Services Division of the Australian National
University, Canberra, ACT, Australia. They were fed rat and
mouse cubes and water ad libitum. The “Principles of laboratory
animal care” (NIH publication no. 86-23, revised 1985) were fol-
lowed, as was the “Australian code of practice for the care and use
of animals for scientific purposes” (NHMRC/CSIRO/AAC).
Induction of EAE
Myelin basic protein-induced acute EAE (acute MBP-EAE)
Myelin basic protein (MBP) was prepared from guinea-pig CNS
tissue by the method of Deibler et al. [6]. MBP in 0.9% saline was
emulsified with an equal volume of incomplete Freund’s adjuvant
containing 4 mg/ml of added Mycobacterium butyricum (Difco,
USA). Ten rats were inoculated by the intradermal injection of 
0.1 ml of emulsion in the footpad of the right hindfoot. The total
dose of MBP was 50 m g/rat. The rats were killed at the onset of
neurological signs [9 days post inoculation (DPI)], 2 days after the
onset of signs (11 DPI), at the peak of neurological signs (13–
14 DPI) and during clinical recovery (15–16 DPI).
Whole spinal cord-induced acute EAE (acute WSC-EAE)
The inoculum was a homogenous mixture of 1 g guinea-pig spinal
cord, 1 ml 0.9% saline, 1 ml complete Freund’s adjuvant (Difco,
USA) and 10 mg M. tuberculosis H37RA (Difco, USA). Ten rats
were inoculated intradermally with 0.1 ml of inoculum in the foot-
pad of the right hindfoot. The rats were killed 2 days (9 DPI) and
1 day (10 DPI) before the usual time of onset of neurological signs,
at the onset of signs (11–12 DPI), 2 days after the onset (13–
14 DPI), at the peak of neurological signs (14–15 DPI) and during
clinical recovery (16–17 DPI).
Chronic relapsing EAE
Chronic relapsing EAE was induced as previously described [25].
Five rats were inoculated intradermally in the footpad of the right
hindfoot with 0.05 ml of the whole spinal cord inoculum. Com-
mencing on the day of inoculation the rats were given subcuta-
neous injections of cyclosporin A (Sandoz; 4 mg/kg) on alternate
days until and including day 22 DPI. Two of the inoculated rats
had a chronic persistent course instead of a chronic relapsing one.
The rats were killed at 30 and 37 DPI at which times there was se-
vere inflammation and demyelination in the spinal cord [25]. Two
normal rats were studied as controls.
Clinical assessment
The rats were examined daily from 7 DPI and also immediately
prior to perfusion for histological and immunocytochemical stud-
ies. Tail, hindlimb and forelimb weakness were each graded on a
scale of 0 (no weakness) to 4 (complete paralysis) [22].
Immunocytochemistry
Under anaesthesia with ketamine, xylazine and atropine, the rats
were perfused via the aorta with 0.9% saline followed by 4%
paraformaldehyde/0.05% glutaraldehyde in 0.1 M phosphate-
buffered saline (PBS) (pH 7.4). Segments of the thoracic, lumbar
and sacral spinal cord and portions of the optic nerve and cerebrum
were removed and further fixed in the above fixative for a total of
3–4 h before being transferred to 0.01 M PBS. Sections (50 and
100 m m) were cut on a TPI vibratome. The Rip monoclonal anti-
body specific for oligodendrocytes [7] was provided by Dr. B.
Friedman (Regeneron Pharmaceuticals, Tarrytown, N.Y.). Anti-
body to glial fibrillary acidic protein (GFAP) expressed by astro-
cytes was obtained from Dako, USA. Mouse monoclonal antibod-
ies against the ab T cell receptor ( ab TCR; R73) and CD11b/c (the
type 3 complement receptor expressed by macrophages and mi-
croglia; OX42) were provided by Dr. J. Sedgwick, Centenary In-
stitute of Cancer Medicine and Cell Biology, Sydney, Australia.
For both light and electron microscopic immunocytochemistry, a
modified protocol of Hsu’s avidin/biotin peroxidase [9] perembed-
ding immunolabelling technique [33] was employed as described
previously [21] and briefly as follows. After endogenous peroxi-
dase and non-specific binding sites had been blocked with 1%
H2O2/0.1% sodium azide solution and with normal goat serum
(Dako) (1:50 in PBS), respectively, vibratome sections were incu-
bated with primary antibodies overnight. Antibody dilutions were
as follows: Rip, 1:2–1:5; R73 and OX42, 1:25; anti-GFAP, 1:100.
Sections were washed with PBS and then incubated overnight with
biotinylated anti-species immunoglobulin G (Vector, USA), 1:300,
containing 1% normal rat serum. After being washed again with
PBS, the sections were incubated with an avidin-biotinylated per-
oxidase complex (Vector, USA). The sections were washed with
PBS and then reacted with 3,3¢ -diaminobenzidine-tetrahydrochlo-
ride (Sigma, USA). Reactions were stopped with PBS, and the 
sections were then washed with saline, re-fixed with modified
Karnovsky’s fixative (2% paraformaldehyde/2.5% glutaraldehyde
in 0.1 M sodium cacodylate buffer, pH 7.3–7.4) and washed in
saline again. The sections were then flat-osmicated and flat-em-
bedded [20]. Semithin sections (1 m m) were examined unstained or
counterstained with toluidine blue. Ultrathin sections were exam-
ined with a Jeol JEM-1200 EXII electron microscope.
Standard light and electron microscopy
Under anaesthesia, the rats were perfused via the aorta with 0.9%
saline followed by modified Karnovsky’s fixative. Thin slices of
the cervical, thoracic, lumbar and sacral spinal cord were removed
for epoxy embedding. The same specimens were also taken from
rats perfused for immunolabelling, after the tissue required for im-
munolabelling had been removed; these specimens were immersed
in the modified Karnovsky’s fixative for at least 24 h before being
processed and embedded in epoxy resin. Semithin sections (0.5
m m) were stained with toluidine blue. Ultrathin sections were
stained with lead citrate and examined with the electron micro-
scope.
Quantification of oligodendrocytes
Rip+ oligodendrocytes in semithin sections of the spinal cord were
quantified by light microscopy with a 40 · objective and the assis-
tance of a 1 · 1-mm eyepiece grid. Only those Rip+ cells with visi-
ble nuclei were counted.
Results
Standard histological findings
In rats with acute MBP-EAE or acute WSC-EAE, inflam-
mation was evident in the spinal cord, with numerous in-
flammatory cells in the meninges, perivascular spaces and
throughout the parenchyma. Primary demyelination was
present from the time of onset of neurological signs and
was most evident in the CNS portions of the dorsal root
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Fig.1 A A lesion in the central tissue projection of the dorsal root
entry zone of the sacral spinal cord of a rat with acute WSC-EAE,
3 days after the onset of neurological signs. Almost all the fibres in
this area are completely demyelinated. A normal PNS portion of
the dorsal root (arrow) can be seen. B An oligodendrocyte (O) is
present in a subpial demyelinated lesion in the white matter of the
sacral spinal cord of a rat with acute WSC-EAE, on the day of on-
set of neurological signs. Demyelinated axons (small arrows) and
macrophages (large arrows) can be seen. C Higher magnification
of the double-arrowed area of the oligodendrocyte in B showing
the characteristic morphological features, namely an organelle-rich
cytoplasm containing numerous free ribosomes, prominent rough
endoplasmic reticulum (long arrows), Golgi apparatus (G) and mi-
crotubules (short arrows). D An oligodendrocyte (O) with processes
that completely embrace (long arrows) or partially invest (short
arrows) demyelinated axons (a) in a subpial spinal cord lesion at
the peak of neurological signs in a rat with acute WSC-EAE. Note
the prominent stringy rough endoplasmic reticulum in the oligo-
dendrocyte cytoplasm, a common morphological feature of the re-
myelinating oligodendrocyte. A Semithin 0.5-m m-thick section
stained with toluidine blue, B–D electron micrographs (WSC-EAE
whole spinal cord-induced acute experimental autoimmune enceph-
alomyelitis, PNS peripheral nervous system). Bars A 10 m m; B,
D 2 m m; C 0.5 m m
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entry and ventral root exit zones (Fig.1A). Cells with the
morphological characteristics of oligodendrocytes, namely
a well-demarcated soma with microtubules, abundant
granular endoplasmic reticulum, numerous free ribosomes
and Golgi apparatus [15, 27], were present in inflamma-
tory demyelinated lesions (Fig.1B, C). At the time of the
peak of neurological signs, oligodendrocyte processes in
the lesions embraced the demyelinated fibres (Fig.1D).
Mitotic cells were present in the grey and white matter
and in the meninges. In rats with chronic relapsing or
chronic persistent EAE, there was severe inflammation
and demyelination at all levels of the spinal cord, espe-
cially the thoracic level.
Immunocytochemical findings
We used the antibody to the ab TCR in acute WSC-EAE
to define the time of onset of the earliest inflammatory le-
sions so that we could determine whether morphological
changes occur in Rip+ oligodendrocytes prior to the onset
of demyelination. Two days before the usual onset of
neurological signs of acute WSC-EAE, ab TCR+ cells
were present in the sacral spinal cord, particularly in the
central tissue projection of the dorsal root entry zone and
in the adjacent meninges, but there was no evidence of
CNS demyelination. These cells constituted the majority
of the inflammatory cells at this stage of the disease. At
the peak of neurological signs CD11b/c+ cells were pre-
sent in large numbers at all spinal cord levels in the three
EAE models. Mitotic CD11b/c+ cells (5 ± 3/sacral spinal
cord transverse section) were seen mostly before the peak
of neurological signs. GFAP+ cells with hypertrophied
processes and cell bodies were present in rats with neuro-
logical signs of EAE but there was no evidence of astro-
cytic damage. Mitotic GFAP+ cells were occasionally
noted.
Rip+ cells were observed at the sites of maximal de-
myelination, including the severely affected central tissue
projection of the dorsal root entry zone, at all stages of
acute EAE from the time of initial ab TCR+ cell infiltra-
tion until after the development of established demyelina-
tion. Within these regions they could be seen contacting
partially or completely demyelinated fibres (Fig. 2A). In
chronic relapsing EAE, Rip+ cells were commonly ob-
served within recently demyelinated areas containing
myelin-laden macrophages (Fig.2B). There were slight
increases in the mean numbers of Rip+ cells in transverse
sections of the sacral spinal cords of rats with EAE com-
pared to normal controls (Table 1), although the differ-
ences were not statistically significant. In the two acute
EAE models, studied at the onset of neurological signs,
occasional (about one cell per two sacral spinal cord
transverse sections) Rip+ cells in the grey matter (Fig.2C)
and the white matter (Fig.2D–F) showed the characteris-
tic morphological features of mitosis. The majority of
these mitotic Rip+ cells had processes in direct contact
with myelin sheaths for considerable lengths, indicating
that they were myelinating oligodendrocytes (Fig. 2E, F).
These mitotic cells were scattered throughout the cross-
sectional area of the spinal cord, and were sometimes lo-
cated at a distance from the sites of demyelination. Mi-
totic Rip+ cells were not observed at later stages of acute
EAE or in rats with chronic relapsing EAE. Pairs of Rip+
cells, but not larger clusters, were found in the spinal
cords of the normal rats; however, the number of pairs and
larger clusters (up to five cells) (Fig.2G) of Rip+ cells was
higher in rats with acute EAE, as previously reported [21].
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Fig.2 A Rip+ oligodendrocytes (large arrows) are present within
a demyelinated lesion in the central tissue projection of the dorsal
root entry zone of the sacral spinal cord. The processes of one of
the oligodendrocytes embrace a fibre being demyelinated (arrow-
head). The processes of another oligodendrocyte are in direct con-
tact with completely demyelinated axons (long thin arrows). Other
demyelinated axons (short arrows) can also be seen. B Rip+ oligo-
dendrocytes (large arrows) and oligodendrocyte processes (small
arrows) are present within a subpial demyelinated plaque in the
thoracic spinal cord. Dilated myelin sheaths (arrowheads) of de-
generating axons can also be seen. C A mitotic Rip+ cell (arrow) at
early prophase in the grey matter of the sacral spinal cord. D A mi-
totic Rip+ cell (large arrow) and a resting Rip+ cell (small arrow)
are present in the white matter of the thoracic spinal cord. E A mi-
totic Rip+ cell (large arrow) in the white matter of the sacral spinal
cord. The processes of the oligodendrocyte are in direct contact
with myelin sheaths (small arrows). A non-labelled astrocyte (ar-
rowhead) is also seen. F A mitotic Rip+ cell (large arrow) is in di-
rect contact with myelin sheaths (small arrows) in the spinal cord.
One of the processes of this cell extends out to a myelinated axon
(arrowhead). Non-mitotic myelin-forming Rip+ oligodendrocytes
(asterisks), which are similarly in direct contact with myelin
sheaths, can be seen. Inflammatory cells (double arrows) are also
present. G A cluster of five oligodendrocytes in the grey matter of
the sacral spinal cord. Three of the cells label more intensely than
the other two, suggesting age differences. Sections, 1 m m thick,
counterstained with toluidine blue from rats with acute WSC-EAE
on the day of onset of neurological signs (A, C–G), and from a rat
with chronic relapsing EAE, 30 DPI (B). Bars 10 m m
F
Table 1 Numbers of Rip+ oligodendrocytes per mm2 in the sacral
spinal cord. Each result was derived from a single transverse sec-
tion. Sections were taken from one or two vibratome block(s) of
the sacral spinal cord from two normal rats, five rats with acute
MBP-EAE (11–16 DPI), three rats with acute WSC-EAE (13–15
DPI) and two rats with chronic persistent EAE (30 DPI). In addi-
tion, the means ± SD are given. Analysis of variance revealed that
there were no significant differences among the groups (MBP-EAE
myelin basic protein-induced experimental autoimmune en-
cephalomyelitis, DPI days post inoculation, WSC-EAE whole
spinal cord-induced EAE)
Normal Acute Acute Chronic  
MBP- WSC- persistent
EAE EAE EAE
164 208 162 178
175 174 180 160
168 162 160 172





Mean ± SD 165 ± 10 175 ± 15 172 ± 10 170 ± 6
These clusters were encountered more often in the grey
than in the white matter. Mitotic Rip+ or CD11b/c+ cells
were not seen in the normal rats.
Using electron microscopy Rip+ myelinating oligoden-
drocytes and their processes could be seen in direct con-
tact with myelin sheaths in normal regions of the spinal
cord (Fig.3A). It was estimated that more than 95% of the
single Rip+ cells in the normal spinal cord, including the
perineuronal satellite cells, were in close contact with at
least one myelinated fibre, albeit often very small. In the
early lesions of acute EAE, Rip+ cells were found in direct
contact with demyelinated axons (Fig.3B–D). Some Rip+
cells directly contacted both demyelinated and normal
myelinated fibres (Fig.3C, D). The majority of the mitotic
cells were CD11b/c+ and had the typical round or oval
shape and rugged processes of macrophages/microglia
(Fig.4A), in contrast to the smooth outline of the less fre-
quent mitotic Rip+ cells (Fig.4B–D). Some of the mitotic
Rip+ cells in the grey matter had no demonstrable contact
44
Fig.3 A–D Electron micrographs of sections labelled with Rip
antibody. A An oligodendrocyte (large arrow) at the junction of
normal white and grey matter (asterisk). The oligodendrocyte cell
body and its processes are in direct contact with many myelin
sheaths (small arrows), indicating that this is a myelin-forming
oligodendrocyte. B Labelled oligodendrocyte processes (small ar-
rows) are in direct contact with demyelinated axons (asterisks) in
an active demyelinating lesion. Macrophages (large arrows) con-
taining myelin debris (arrowheads) are seen nearby. C An oligo-
dendrocyte (large asterisk) with its labelled cell body and
processes in direct contact with both demyelinated axons (small
arrows) and normal-appearing myelinated fibres (large arrows).
The gaps (small asterisks) between the myelin sheaths and the
oligodendrocyte are processing artefacts. D An oligodendrocyte
(arrow) with its processes in direct contact with demyelinated ax-
ons (asterisks) and a normal-appearing myelinated fibre (small ar-
row). A macrophage (arrowhead) containing myelin debris can be
seen. All sections are from rats with acute WSC-EAE on the day of
onset of neurological signs. Bars 2 m m
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Fig.4 A A mitotic CD11b/c+ cell with rugged processes is present
in the spinal cord. A resting CD11b/c+ macrophage or microglial
cell (large arrow) and demyelinated axons (small arrows) can also
be seen. B A mitotic Rip+ cell (large arrow) at early anaphase lies
adjacent to a resting Rip+ cell (arrowhead) in the grey matter of the
spinal cord. The mitotic cell is less intensely labelled than the rest-
ing cell. A non-labelled mononuclear leukocyte (small arrow) is
also seen. C A mitotic Rip+ myelin-forming oligodendrocyte with
its cell body and processes in direct contact with normal myelin
sheaths (arrows) in the spinal cord white matter. D Higher magni-
fication of the region in C indicated by arrowheads showing Rip+
oligodendrocyte processes (arrows) in direct contact with myelin
sheaths for considerable lengths. A Rat with acute myelin basic
protein-induced EAE; B–D rats with acute WSC-EAE on the day
of onset of neurological signs. Bars A–C 2 m m; D 0.5 m m
with myelin sheaths (Fig.4B) but the majority of mitotic
Rip+ cells had processes in direct contact with myelin
sheaths for considerable lengths (Fig.4C, D), indicating
that they were myelin-forming oligodendrocytes. Mitotic
Rip+ cells usually labelled less intensely than resting Rip+
cells (Fig.4B). There was no evidence of oligodendrocyte
apoptosis or necrosis in any of the three EAE models. We
did not find any evidence of dying-back gliopathy as
found in other conditions [18, 31].
Discussion
In the present study we have used pre-embedding immuno-
labelling with the Rip monoclonal antibody, which specifi-
cally labels the cytoplasm of mature oligodendrocytes but
not oligodendroglial progenitors [30], to study the fate of
oligodendrocytes in the CNS in EAE. We have shown that
oligodendrocytes survive the acute demyelinating insult in
EAE and that mature myelinating oligodendrocytes are
able to undergo mitosis. Using the Rip antibody we did not
identify any apoptotic oligodendrocytes which, on the basis
of standard light and electron microscopy, we have previ-
ously suggested might occur in the CNS in EAE in addition
to apoptotic mononuclear leukocytes [26].
Oligodendrocytes were observed at the sites of maxi-
mal demyelination, including the severely affected central
tissue projection of the dorsal root entry zone, at all stages
of the disease from the time of the initial ab T cell infil-
tration until after the development of established demyeli-
nation. The presence of morphologically normal oligo-
dendrocytes in direct contact with fibres in the process of
being demyelinated indicates that these cells are surviving
myelinating oligodendrocytes rather than newly generated
or recruited oligodendrocytes. The presence of surviving
oligodendrocytes and the absence of oligodendrocyte apop-
tosis or necrosis indicate that myelin, not the oligodendro-
cyte, is the primary target of the immune attack in EAE.
The direct contact between individual normal oligoden-
drocytes and both myelinated and demyelinated fibres
(Fig.3C, D) further supports this conclusion. Neverthe-
less, it remains possible that a sublethal injury to oligo-
dendrocytes might contribute to the demyelinating process.
Oligodendrocytes isolated from the adult rat are able to
undergo mitosis in vitro [34] and mitotic myelin-forming
oligodendrocytes have been identified by standard light
microscopy in the normal developing mouse CNS [32].
However, it has been unclear whether mature myelin-
forming oligodendrocytes are able to proliferate in the
adult CNS in vivo. Some studies have reported the incor-
poration of tritiated thymidine into the nuclei of mature
oligodendrocytes [1, 8, 16, 17, 28] as evidence of oligo-
dendrocyte proliferation, but the nuclear incorporation of
tritiated thymidine is not specific for mitosis, as it can also
occur during DNA repair [35]. The percentages of incor-
porating cells were very high in some studies [8, 28] de-
spite the absence of mitotic figures.
To our knowledge the present study is the first to de-
scribe immunocytochemically identified myelinating oligo-
dendrocytes displaying mitotic features in situ, in the
adult CNS. Pre-embedding immunolabelling with the Rip
antibody, which specifically labels the cytoplasm of both
the oligodendrocyte cell body and its processes [3, 7], re-
vealed that the processes of mitotic oligodendrocytes
were in direct contact with myelin sheaths for consider-
able lengths. Nevertheless, mitosis of mature oligoden-
drocytes was an infrequently observed event. This is con-
sistent with the statistically insignificant increase in the
total number of oligodendrocytes in spinal cord sections.
Our finding of mitotic Rip+ oligodendrocytes is in con-
trast to the results of a recent study which found that Rip+
oligodendrocytes do not incorporate bromodeoxyuridine
in rats with CNS demyelination induced after spinal cord
irradiation and which concluded that mature oligodendro-
cytes do not undergo mitosis [11]. The mitosis of myeli-
nating oligodendrocytes is likely to contribute to the for-
mation of the oligodendrocyte clusters observed in the
present and a previous study [21]. It may also provide one
source of the oligodendrocytes that remyelinate the CNS
during clinical recovery from EAE [12, 14, 23–25].
Although the factors inducing the mitosis of mature
oligodendrocytes in EAE are as yet undetermined, the oc-
currence of mitotic oligodendrocytes at some distance
from the sites of demyelination and at the onset of neuro-
logical signs suggests that soluble factors released by
CNS parenchymal cells or inflammatory cells might be
responsible. For example, the proliferation of oligoden-
drocytes could be triggered by T cell-derived cytokines
such as tumour necrosis factor, which stimulates the pro-
liferation of many cell types, or interleukin-2, which stim-
ulates oligodendrocyte proliferation [2]. Although the
mechanism of demyelination in multiple sclerosis may
differ from that in EAE, our finding of survival and mito-
sis of myelinating oligodendrocytes in EAE may boost the
search for factors that facilitate remyelination by increas-
ing the number of myelinating oligodendrocytes.
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